BAYER AKTIENGESELLSCHAFT Chart calendar Bayer Aktiengesellschaft
fc2ab3d803cbdc2ec.cJwnMptd2dNzDkNSHSdvAkuVD5p2Kj63JPwFtA2ZTf8.QOsSZNk8rIYKYwgHbFIAaTH5R8skcHbcc8g83mvcHZBIw2BcqmW3m0JvDg~a8768f1deeccdaf5c59ec911155c9bd6
Upcoming events on Bayer Aktiengesellschaft
Past events on Bayer Aktiengesellschaft
| 2024-04-28 | Ex-dividend day for final dividend |
| 2024-04-26 04:00 am | Annual General Meeting |
| 2024-03-05 08:00 am | Capital Markets Day - Q4 2023 Earnings |
| 2024-03-05 03:30 am | Q4 2023 Earnings Call |
| 2024-03-05 01:30 am | Q4 2023 Earnings Release |
| 2024-01-15 02:00 am | UniCredit Kepler Cheuvreux German Corporate Conference |
| 2024-01-09 02:15 pm | JPMorgan Healthcare Conference |
| 2023-11-21 08:00 am | OCEANIC-AF Phase III Trial Update Call |
| 2023-11-08 08:00 am | Q3 2023 Earnings Call |
| 2023-11-08 01:30 am | Q3 2023 Earnings Release |
| 2023-10-19 | European Society for Medical Oncology Congress |
| 2023-09-26 | Citi European Healthcare Bus Tour |
| 2023-09-18 | Goldman Sachs Corporate Conference |
| 2023-09-11 | Morgan Stanley Global Healthcare Conference |
| 2023-08-08 08:00 am | Q2 2023 Earnings Call |
| 2023-08-08 01:30 am | Q2 2023 Earnings Release |
| 2023-06-28 08:00 am | R&D Day - Pharmaceuticals |
| 2023-06-20 09:00 am | Crop Science Innovation Summit |
| 2023-05-16 | BMO Chemicals Conference |
| 2023-05-11 08:00 am | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 43 545 43 968 -0.96% | 41 400 41 796 -0.95% | 44 081 43 294 1.82% | 50 739 50 664 0.15% | 47 637 47 587 0.1% | 47 090 |
|
EBITDA Million EUR | Released Forecast Spread | 11 503 11 611 -0.93% | 11 461 11 726 -2.26% | 11 179 11 149 0.27% | 13 513 13 377 1.02% | 10 632 11 031 -3.62% | 10 254 |
|
EBIT Million EUR | Released Forecast Spread | 7 007 7 922 -11.55% | 7 095 7 073 0.31% | 7 295 7 420 -1.68% | 9 257 8 940 3.55% | 7 589 7 381 2.82% | 6 615 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2 880 3 826 -24.73% | -17 250 -18 018 4.26% | 2 046 1 237 65.4% | 4 670 5 985 -21.97% | -1 621 -1 358 -19.36% | 3 252 |
|
Net income Million EUR | Released Forecast Spread | 4 091 3 123 30.99% | -10 495 -12 097 13.24% | 1 000 671 49.02% | 4 150 4 435 -6.43% | -2 941 -1 998 -47.23% | 2 081 |
|
EPS EUR | Released Forecast Spread | 4,17 2,95 41.34% | -10,7 -13,3 19.9% | 1,02 0,64 59.65% | 4,22 4,48 -5.85% | -2,99 -3,02 0.95% | 2,19 |
| Announcement Date | 27/02/20 | 25/02/21 | 01/03/22 | 28/02/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 22 899 23 681 -3.3% | 18 501 18 540 -0.21% | 11 118 10 530 5.58% | 14 639 13 729 6.63% | 12 819 12 281 4.38% | 11 281 10 946 3.06% | 12 000 12 078 -0.65% | 14 389 14 585 -1.34% | 11 044 11 847 -6.78% | 10 342 10 448 -1.01% | 11 862 11 731 1.12% | 14 092 | 11 031 | 25 032 | 10 377 | 11 875 | 22 305 |
|
EBITDA Million EUR | Released Forecast Spread | 7 274 17 926 -59.42% | 2 395 2 365 1.25% | 5 251 4 692 11.92% | 3 349 3 188 5.05% | 2 451 2 388 2.63% | 2 462 2 574 -4.34% | 4 471 4 650 -3.85% | 2 527 2 694 -6.19% | 1 685 1 801 -6.46% | 3 023 2 276 32.83% | 4 253 | 2 387 | 6 559 | 1 620 | 2 434 | 4 109 | |
|
EBIT Million EUR | Released Forecast Spread | 1 383 1 344 2.92% | 4 172 3 625 15.08% | 2 280 2 200 3.62% | 1 352 1 329 1.75% | 1 453 1 792 -18.92% | 3 404 3 210 6.03% | 1 534 1 312 16.9% | 709 958 -26.01% | 1 942 1 849 5.02% | 2 733 | 1 516 | 1 022 | 1 309 | ||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 497 170 780.59% | 3 722 2 955 25.98% | -523 1 556 -133.61% | 601 941 -36.13% | 870 1 808 -51.87% | 2 606 2 569 1.46% | -1 574 234 -772.65% | -4 297 680 -731.91% | 1 644 673 144.28% | ||||||||
|
Net income Million EUR | Released Forecast Spread | 1 161 755 53.87% | 3 291 2 314 42.23% | -298 1 293 -123.05% | 546 570 -4.19% | 611 853 -28.39% | 2 178 1 872 16.34% | -1 887 | -4 569 393 -1262.9% | 1 337 584 128.86% | 1 438 | 500 | 2 308 | 23,8 | 167 | 422 | ||
|
EPS EUR | Released Forecast Spread | 1,18 0,65 81.71% | 3,35 2,36 42.14% | -0,30 1,31 -122.87% | 0,56 0,60 -6.62% | 0,62 0,97 -36.28% | 2,22 1,90 16.6% | -1,92 | -4,66 0,41 -1226.26% | 1,36 0,59 128.58% | 1,46 | 0,51 | 2,35 | 0,02 | 0,17 | 0,43 | ||
| Announcement Date | 04/08/20 | 25/02/21 | 01/03/22 | 10/05/22 | 04/08/22 | 08/11/22 | 28/02/23 | 11/05/23 | 08/08/23 | 08/11/23 | 05/03/24 | - | - | - | - | - | - |
More events
Past sector events for Bayer Aktiengesellschaft
| 2024-05-03 07:07 am | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 2024-05-03 06:00 am | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 04:01 pm | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:43 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:30 am | ORGANON & CO.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 2024-05-01 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
